By Uduak Grace Thomas

In a bid to identify biomarkers that could predict a patient's response to asthma therapies and to provide insights that could lead to better treatments for the disease, GNS Healthcare is lending its bioinformatics expertise and Reverse Engineering Forward Simulation platform to a project that aims to develop a predictive model for asthma based on data collected during a clinical trial.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.